Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

Pharmacogenomics promises to advance cardiovascular therapy, but there remain pragmatic barriers to implementation. These are particularly important to explore within Europe, as there are differences in the populations, availability of resources, and expertise, as well as in ethico-legal frameworks....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY 2021-08, Vol.8 (1), p.100-103
Hauptverfasser:	Magavern, Emma F, Kaski, Juan Carlos, Turner, Richard M, Drexel, Heinz, Janmohamed, Azara, Scourfield, Andrew, Burrage, Daniel, Floyd, Christopher N, Adeyeye, Elizabeth, Tamargo, Juan, Lewis, Basil S, Kjeldsen, Keld Per, Niessner, Alexander, Wassmann, Sven, Sulzgruber, Patrick, Borry, Pascal, Agewall, Stefan, Semb, Anne Grete, Savarese, Gianluigi, Pirmohamed, Munir, Caulfield, Mark J
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!